KDM7A and neoplasm: We found that 47 of the 88 KDM7A-DT-defined EMT Type II pathway–associated gene signatures downregulated upon its over-expression in MRC5 cells were categorized as oncogenes and tumor-suppressors (Supplementary Figure S9, Supplementary Table S12).